Literature DB >> 33406628

Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson's Disease.

Peipei Li1, Bryan A Killinger1,2, Elizabeth Ensink1, Ian Beddows3, Ali Yilmaz4,5, Noah Lubben1, Jared Lamp6, Meghan Schilthuis1, Irving E Vega6, Randy Woltjer7, J Andrew Pospisilik3, Patrik Brundin1,8, Lena Brundin1,8, Stewart F Graham4,5, Viviane Labrie1,8.   

Abstract

The gut microbiome can impact brain health and is altered in Parkinson's disease (PD). The vermiform appendix is a lymphoid tissue in the cecum implicated in the storage and regulation of the gut microbiota. We sought to determine whether the appendix microbiome is altered in PD and to analyze the biological consequences of the microbial alterations. We investigated the changes in the functional microbiota in the appendix of PD patients relative to controls (n = 12 PD, 16 C) by metatranscriptomic analysis. We found microbial dysbiosis affecting lipid metabolism, including an upregulation of bacteria responsible for secondary bile acid synthesis. We then quantitatively measure changes in bile acid abundance in PD relative to the controls in the appendix (n = 15 PD, 12 C) and ileum (n = 20 PD, 20 C). Bile acid analysis in the PD appendix reveals an increase in hydrophobic and secondary bile acids, deoxycholic acid (DCA) and lithocholic acid (LCA). Further proteomic and transcriptomic analysis in the appendix and ileum corroborated these findings, highlighting changes in the PD gut that are consistent with a disruption in bile acid control, including alterations in mediators of cholesterol homeostasis and lipid metabolism. Microbially derived toxic bile acids are heightened in PD, which suggests biliary abnormalities may play a role in PD pathogenesis.

Entities:  

Keywords:  Parkinson’s disease; appendix; bile acids; gut; microbiome

Year:  2021        PMID: 33406628      PMCID: PMC7823437          DOI: 10.3390/metabo11010029

Source DB:  PubMed          Journal:  Metabolites        ISSN: 2218-1989


  67 in total

1.  Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells.

Authors:  Chi Ma; Miaojun Han; Bernd Heinrich; Qiong Fu; Qianfei Zhang; Milan Sandhu; David Agdashian; Masaki Terabe; Jay A Berzofsky; Valerie Fako; Thomas Ritz; Thomas Longerich; Casey M Theriot; John A McCulloch; Soumen Roy; Wuxing Yuan; Vishal Thovarai; Shurjo K Sen; Mathuros Ruchirawat; Firouzeh Korangy; Xin Wei Wang; Giorgio Trinchieri; Tim F Greten
Journal:  Science       Date:  2018-05-25       Impact factor: 47.728

Review 2.  Parkinson's disease.

Authors:  Lorraine V Kalia; Anthony E Lang
Journal:  Lancet       Date:  2015-04-19       Impact factor: 79.321

Review 3.  Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism.

Authors:  Annika Wahlström; Sama I Sayin; Hanns-Ulrich Marschall; Fredrik Bäckhed
Journal:  Cell Metab       Date:  2016-06-16       Impact factor: 27.287

4.  Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.

Authors:  Henri Duboc; Sylvie Rajca; Dominique Rainteau; David Benarous; Marie-Anne Maubert; Elodie Quervain; Ginette Thomas; Véronique Barbu; Lydie Humbert; Guillaume Despras; Chantal Bridonneau; Fabien Dumetz; Jean-Pierre Grill; Joëlle Masliah; Laurent Beaugerie; Jacques Cosnes; Olivier Chazouillères; Raoul Poupon; Claude Wolf; Jean-Maurice Mallet; Philippe Langella; Germain Trugnan; Harry Sokol; Philippe Seksik
Journal:  Gut       Date:  2012-09-19       Impact factor: 23.059

Review 5.  Emerging roles of bile acids in mucosal immunity and inflammation.

Authors:  Mei Lan Chen; Kiyoshi Takeda; Mark S Sundrud
Journal:  Mucosal Immunol       Date:  2019-04-05       Impact factor: 7.313

Review 6.  Systematic review: bile acids and intestinal inflammation-luminal aggressors or regulators of mucosal defence?

Authors:  P Pavlidis; N Powell; R P Vincent; D Ehrlich; I Bjarnason; B Hayee
Journal:  Aliment Pharmacol Ther       Date:  2015-07-29       Impact factor: 8.171

Review 7.  Triggers, Facilitators, and Aggravators: Redefining Parkinson's Disease Pathogenesis.

Authors:  Michaela E Johnson; Benjamin Stecher; Viviane Labrie; Lena Brundin; Patrik Brundin
Journal:  Trends Neurosci       Date:  2018-10-17       Impact factor: 13.837

8.  Metagenomic microbial community profiling using unique clade-specific marker genes.

Authors:  Nicola Segata; Levi Waldron; Annalisa Ballarini; Vagheesh Narasimhan; Olivier Jousson; Curtis Huttenhower
Journal:  Nat Methods       Date:  2012-06-10       Impact factor: 28.547

9.  The Appendix in Parkinson's Disease: From Vestigial Remnant to Vital Organ?

Authors:  Bryan Killinger; Viviane Labrie
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

10.  Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota.

Authors:  Severin Weis; Andreas Schwiertz; Marcus M Unger; Anouck Becker; Klaus Faßbender; Stefan Ratering; Matthias Kohl; Sylvia Schnell; Karl-Herbert Schäfer; Markus Egert
Journal:  NPJ Parkinsons Dis       Date:  2019-11-29
View more
  17 in total

Review 1.  The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic.

Authors:  Ai Huey Tan; Shen Yang Lim; Anthony E Lang
Journal:  Nat Rev Neurol       Date:  2022-06-24       Impact factor: 44.711

2.  Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status.

Authors:  Robin M Voigt; Zeneng Wang; J Mark Brown; Phillip A Engen; Ankur Naqib; Christopher G Goetz; Deborah A Hall; Leo Verhagen Metman; Maliha Shaikh; Christopher B Forsyth; Ali Keshavarzian
Journal:  Neurobiol Dis       Date:  2022-05-30       Impact factor: 7.046

3.  Distinct Bile Acid Signature in Parkinson's Disease With Mild Cognitive Impairment.

Authors:  Kun Nie; Yanyi Li; Jiahui Zhang; Yuyuan Gao; Yihui Qiu; Rong Gan; Yuhu Zhang; Lijuan Wang
Journal:  Front Neurol       Date:  2022-07-04       Impact factor: 4.086

Review 4.  Metabolic Diffusion in Neuropathologies: The Relevance of Brain-Liver Axis.

Authors:  Sergio Vegas-Suárez; Jorge Simón; María Luz Martínez-Chantar; Rosario Moratalla
Journal:  Front Physiol       Date:  2022-05-12       Impact factor: 4.755

Review 5.  Regulation of common neurological disorders by gut microbial metabolites.

Authors:  Jeongho Park; Chang H Kim
Journal:  Exp Mol Med       Date:  2021-12-02       Impact factor: 8.718

Review 6.  Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease.

Authors:  Steven N Austad; Scott Ballinger; Thomas W Buford; Christy S Carter; Daniel L Smith; Victor Darley-Usmar; Jianhua Zhang
Journal:  Acta Pharm Sin B       Date:  2021-06-30       Impact factor: 11.413

7.  Methylated Cytochrome P450 and the Solute Carrier Family of Genes Correlate With Perturbations in Bile Acid Metabolism in Parkinson's Disease.

Authors:  Sangeetha Vishweswaraiah; Sumeyya Akyol; Ali Yilmaz; Zafer Ugur; Juozas Gordevičius; Kyung Joon Oh; Patrik Brundin; Uppala Radhakrishna; Viviane Labrie; Stewart F Graham
Journal:  Front Neurosci       Date:  2022-03-31       Impact factor: 4.677

Review 8.  Gut Microbiota Metabolites in Major Depressive Disorder-Deep Insights into Their Pathophysiological Role and Potential Translational Applications.

Authors:  Miguel A Ortega; Miguel Angel Alvarez-Mon; Cielo García-Montero; Oscar Fraile-Martinez; Luis G Guijarro; Guillermo Lahera; Jorge Monserrat; Paula Valls; Fernando Mora; Roberto Rodríguez-Jiménez; Javier Quintero; Melchor Álvarez-Mon
Journal:  Metabolites       Date:  2022-01-08

9.  The Cerebrospinal Fluid Profile of Cholesterol Metabolites in Parkinson's Disease and Their Association With Disease State and Clinical Features.

Authors:  William J Griffiths; Jonas Abdel-Khalik; Sarah F Moore; Ruwani S Wijeyekoon; Peter J Crick; Eylan Yutuc; Krista Farrell; David P Breen; Caroline H Williams-Gray; Spyridon Theofilopoulos; Ernest Arenas; Miles Trupp; Roger A Barker; Yuqin Wang
Journal:  Front Aging Neurosci       Date:  2021-08-30       Impact factor: 5.750

10.  Gut Microbiota-Mediated Elevated Production of Secondary Bile Acids in Chronic Unpredictable Mild Stress.

Authors:  Yuchen Qu; Cunjin Su; Qinhong Zhao; Aiming Shi; Fenglun Zhao; Liuxing Tang; Delai Xu; Zheng Xiang; Yang Wang; Yueyuan Wang; Jie Pan; Yunli Yu
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.